Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Defining the immunosuppressive milieu of prostate cancer with single cell Omics technologies

Project description

Delineating prostate cancer cell interaction with the immune system

Emerging evidence indicates that the immune system has the intriguing ability to both promote and suppress cancer onset and progression. Therefore, it is necessary to understand its role in each cancer type separately. The EU-funded milieuPCa project focuses on prostate cancer and aims to perform a multiparametric analysis at the single-cell level using omics technologies. Project results will unveil cancer cell interaction with the immune system and help understand biological mechanisms as well as identify new cancer biomarkers. Collectively, this information will lead to the design of immunotherapy strategies specific for prostate cancer.

Objective

The immune contexture of prostate cancer is poorly studied, despite among researchers there is a strong interest in developing immunotherapy approaches to cure the disease. It is known that the immune system can have a dual role in the tumor progression, in other words, it can either promote or suppress tumor growth and invasion. However, the immunomodulation of prostate cancer and the immunosuppressive mechanisms involved are still not entirely known. In this proposal, I suggest using and integrating Omics data from various sources to give a holistic and comprehensive overview of the immune milieu of prostate cancer at a single cell level. Human prostate cancer samples will be used to generate transcriptomics with scRNA-Seq, epigenomics with scATAC-Seq and multiplexed images with the Hyperion system. Transcriptomics and epigenomics data at the single cell level will allow the classification of the cell types at the molecular level, the delineation of related biomarkers and biological mechanisms as well as the establishment of a prostate cancer specific deconvolution approach. Spatial information will be obtained for candidate biomarkers found through scRNA-Seq and scATA-Seq, and all data will be then integrated in order to create a link between transcriptional regulation, signaling pathways and cell-cell interaction. High throughput data integration in prostate cancer will allow elucidation of the biological mechanisms involved in an unprecedented level. This study will be a powerful resource for future basic studies on prostate cancer, but also for guiding the development of novel immunotherapy approaches.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

MSCA-IF - Marie Skłodowska-Curie Individual Fellowships (IF)

See all projects funded under this funding scheme

Call for proposal

(opens in new window) H2020-MSCA-IF-2020

See all projects funded under this call

Coordinator

UNIVERSITAETSKLINIKUM FREIBURG
Net EU contribution
€ 174 806,40
Address
HUGSTETTER STRASSE 49
79106 Freiburg
Germany
Region
Baden-Württemberg Freiburg Freiburg im Breisgau, Stadtkreis
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 174 806,40